Search Results - "Bateman, Eric D"

The paradoxes of asthma management: time for a new approach? by O'Byrne, Paul M, Jenkins, Christine, Bateman, Eric D

“…Poor adherence to maintenance pharmacotherapy is a reality in asthma. Studies confirm that when symptoms worsen, most patients increase short-acting β -agonist…”
Get full text

Global asthma prevalence in adults: findings from the cross-sectional world health survey by To, Teresa, Stanojevic, Sanja, Moores, Ginette, Gershon, Andrea S, Bateman, Eric D, Cruz, Alvaro A, Boulet, Louis-Philippe

“…Asthma is a major cause of disability, health resource utilization and poor quality of life world-wide. We set out to generate estimates of the global burden…”
Get full text

Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes by Reddel, Helen K, Bacharier, Leonard B, Bateman, Eric D, Brightling, Christopher E, Brusselle, Guy G, Buhl, Roland, Cruz, Alvaro A, Duijts, Liesbeth, Drazen, Jeffrey M, FitzGerald, J Mark, Fleming, Louise J, Inoue, Hiromasa, Ko, Fanny W, Krishnan, Jerry A, Levy, Mark L, Lin, Jiangtao, Mortimer, Kevin, Pitrez, Paulo M, Sheikh, Aziz, Yorgancioglu, Arzu A, Boulet, Louis-Philippe

“…The Global Initiative for Asthma (GINA) Strategy Report provides clinicians with an annually updated evidence-based strategy for asthma management and…”
Get full text

Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials by Castro, Mario, Prof, Zangrilli, James, MD, Wechsler, Michael E, Prof, Bateman, Eric D, Prof, Brusselle, Guy G, Prof, Bardin, Philip, Prof, Murphy, Kevin, MD, Maspero, Jorge F, MD, O'Brien, Christopher, MD, Korn, Stephanie, MD

“…Summary Background Elevated numbers of blood eosinophils are a risk factor for asthma exacerbations. Reslizumab is a humanised anti-interleukin 5 monoclonal…”
Get full text

The asthma–COPD overlap syndrome: towards a revised taxonomy of chronic airways diseases? by Bateman, Eric D, Prof, Reddel, Helen K, MBBS, van Zyl-Smit, Richard N, MBChB, Agusti, Alvar, MD

“…Summary Most research of treatments for airways diseases has been restricted to patients who meet standard definitions of either chronic obstructive pulmonary…”
Get full text

A summary of the new GINA strategy: a roadmap to asthma control by Reddel, Helen K, Bateman, Eric D, Becker, Allan, Boulet, Louis-Philippe, Cruz, Alvaro A, Drazen, Jeffrey M, Haahtela, Tari, Hurd, Suzanne S, Inoue, Hiromasa, de Jongste, Johan C, Lemanske, Jr, Robert F, Levy, Mark L, O'Byrne, Paul M, Paggiaro, Pierluigi, Pedersen, Soren E, Pizzichini, Emilio, Soto-Quiroz, Manuel, Szefler, Stanley J, Wong, Gary W K, FitzGerald, J Mark

“…Over the past 20 years, the Global Initiative for Asthma (GINA) has regularly published and annually updated a global strategy for asthma management and…”
Get full text

Tiotropium add-on therapy in adolescents with moderate asthma: A 1-year randomized controlled trial by Hamelmann, Eckard, MD, Bateman, Eric D., MD, Vogelberg, Christian, MD, Szefler, Stanley J., MD, Vandewalker, Mark, MD, Moroni-Zentgraf, Petra, MD, Avis, Mandy, PhD, Unseld, Anna, MSc, Engel, Michael, MD, Boner, Attilio L., MD

“…Background Results from phase III clinical trials in adults and phase II clinical trials in children and adolescents demonstrate that tiotropium is an…”
Get full text

Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials by Hanania, Nicola A, Dr, Korenblat, Phillip, Prof, Chapman, Kenneth R, Prof, Bateman, Eric D, Prof, Kopecky, Petr, MD, Paggiaro, Pierluigi, Prof, Yokoyama, Akihito, Prof, Olsson, Julie, MD, Gray, Sarah, PhD, Holweg, Cecile T J, PhD, Eisner, Mark, MD, Asare, Charles, MD, Fischer, Saloumeh K, PhD, Peng, Kun, PhD, Putnam, Wendy S, PhD, Matthews, John G, MB BS

“…Summary Background In phase 2 trials, lebrikizumab, an anti-interleukin-13 monoclonal antibody, reduced exacerbation rates and improved FEV1 in patients with…”
Get full text

Efficacy and safety of twice-daily aclidinium bromide in COPD patients: the ATTAIN study by JONES, Paul W, SINGH, Dave, BATEMAN, Eric D, AGUSTI, Alvar, LAMARCA, Rosa, DE MIQUEL, Gonzalo, SEGARRA, Rosa, CARACTA, Cynthia, GARCIA GIL, Esther

“…The efficacy and safety of two doses of aclidinium bromide were evaluated in patients with moderate to severe chronic obstructive pulmonary disease (COPD). In…”
Get full text

Roflumilast combined with montelukast versus montelukast alone as add-on treatment in patients with moderate-to-severe asthma by Bateman, Eric D., MD, Goehring, Udo-Michael, MD, Richard, Frank, MD, Watz, Henrik, MD

“…Background Roflumilast, a selective phosphodiesterase 4 inhibitor, has been shown to provide modest improvements in lung function in patients with…”
Get full text

Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol–fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group study by Vogelmeier, Claus F, Prof, Bateman, Eric D, Prof, Pallante, John, BS, Alagappan, Vijay KT, MD, D'Andrea, Peter, MD, Chen, Hungta, PhD, Banerji, Donald, MD

“…Summary Background QVA149 is an inhaled fixed-dose combination therapy under development for the treatment of chronic obstructive pulmonary disease (COPD). It…”
Get full text

Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma by Bateman, Eric D., MD, Kornmann, Oliver, MD, Schmidt, Peter, PhD, Pivovarova, Anna, DiplStat, Engel, Michael, MD, Fabbri, Leonardo M., MD

“…Background The efficacy and safety of inhaled long-acting β2 -adrenergic agonists in asthmatic patients with the B16-Arg/Arg genotype has been questioned, and…”
Get full text

Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes by Reddel, Helen K., Bacharier, Leonard B., Bateman, Eric D., Brightling, Christopher E., Brusselle, Guy G., Buhl, Roland, Cruz, Alvaro A., Duijts, Liesbeth, Drazen, Jeffrey M., FitzGerald, J. Mark, Fleming, Louise J., Inoue, Hiromasa, Ko, Fanny W., Krishnan, Jerry A., Levy, Mark L., Lin, Jiangtao, Mortimer, Kevin, Pitrez, Paulo M., Sheikh, Aziz, Yorgancioglu, Arzu A., Boulet, Louis-Philippe

“…The Global Initiative for Asthma (GINA) Strategy Report provides clinicians with an annually updated evidence-based strategy for asthma management and…”
Get full text

Educational Outreach with an Integrated Clinical Tool for Nurse-Led Non-communicable Chronic Disease Management in Primary Care in South Africa: A Pragmatic Cluster Randomised Controlled Trial by Fairall, Lara R, Folb, Naomi, Timmerman, Venessa, Lombard, Carl, Steyn, Krisela, Bachmann, Max O, Bateman, Eric D, Lund, Crick, Cornick, Ruth, Faris, Gill, Gaziano, Thomas, Georgeu-Pepper, Daniella, Zwarenstein, Merrick, Levitt, Naomi S

“…In many low-income countries, care for patients with non-communicable diseases (NCDs) and mental health conditions is provided by nurses. The benefits of nurse…”
Get full text

Overall asthma control: The relationship between current control and future risk by Bateman, Eric D., MD, Reddel, Helen K., MBBS, PhD, FRACP, Eriksson, Göran, MB, PhD, Peterson, Stefan, PhD, Östlund, Ollie, PhD, Sears, Malcolm R., MB, FRACP, FRCPC, Jenkins, Christine, MD, FRACP, Humbert, Marc, MD, Buhl, Roland, MD, Harrison, Tim W., MD, Quirce, Santiago, MD, PhD, O'Byrne, Paul M., MB, FRCP(C)

“…Background Asthma guidelines emphasize both maintaining current control and reducing future risk, but the relationship between these 2 targets is not well…”
Get full text

Development and validation of a novel risk score for asthma exacerbations: The risk score for exacerbations by Bateman, Eric D., MD, Buhl, Roland, MD, O'Byrne, Paul M., MB, FRCPC, Humbert, Marc, MD, Reddel, Helen K., MBBS, PhD, FRACP, Sears, Malcolm R., MB, FRACP, FRCPC, Jenkins, Christine, MD, FRACP, Harrison, Tim W., MD, Quirce, Santiago, MD, PhD, Peterson, Stefan, PhD, Eriksson, Göran, MB, PhD

“…Background Identifying patients at risk of future severe asthma exacerbations, those whose asthma might be less treatment responsive, or both might guide…”
Get full text

Tiotropium or salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate, double-blind, placebo-controlled, parallel-group, active-comparator, randomised trials by Kerstjens, Huib A M, Prof, Casale, Thomas B, Prof, Bleecker, Eugene R, Prof, Meltzer, Eli O, MD, Pizzichini, Emilio, Prof, Schmidt, Olaf, MD, Engel, Michael, MD, Bour, Loek, MSc, Verkleij, Cynthia B, BSc, Moroni-Zentgraf, Petra, MD, Bateman, Eric D, Prof

“…Summary Background In patients with severe asthma, tiotropium improves lung function and exacerbation risk when added to high-dose inhaled corticosteroids plus…”
Get full text

Magnitude of effect of asthma treatments on Asthma Quality of Life Questionnaire and Asthma Control Questionnaire scores: Systematic review and network meta-analysis by Bateman, Eric D., MD, Esser, Dirk, PhD, Chirila, Costel, PhD, Fernandez, Maria, PhD, MBA, Fowler, Andy, MD, Moroni-Zentgraf, Petra, MD, FitzGerald, J. Mark, MD

“…Background The Asthma Quality of Life Questionnaire (AQLQ) and the Asthma Control Questionnaire (ACQ) are widely used in asthma research; however, in studies…”
Get full text

Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes by Reddel, Helen K., Bacharier, Leonard B., Bateman, Eric D., Brightling, Christopher E., Brusselle, Guy G., Buhl, Roland, Cruz, Alvaro A., Duijts, Liesbeth, Drazen, Jeffrey M., FitzGerald, J. Mark, Fleming, Louise J., Inoue, Hiromasa, Ko, Fanny W., Krishnan, Jerry A., Levy, Mark L., Lin, Jiangtao, Mortimer, Kevin, Pitrez, Paulo M., Sheikh, Aziz, Yorgancioglu, Arzu A., Boulet, Louis-Philippe

“…The Global Initiative for Asthma (GINA) Strategy Report provides clinicians with an annually updated evidence-based strategy for asthma management and…”
Get full text

Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort by Jones, Rupert C M, MD, Price, David, Prof, Ryan, Dermot, MD, Sims, Erika J, PhD, von Ziegenweidt, Julie, Mascarenhas, Laurence, MSc, Burden, Anne, MSc, Halpin, David M G, DPhil, Winter, Robert, MD, Hill, Sue, Prof, Kearney, Matt, MRCGP, Holton, Kevin, Moger, Anne, MSc, Freeman, Daryl, MRCGP, Chisholm, Alison, MSc, Bateman, Eric D, Prof

“…Summary Background Patterns of health-care use and comorbidities present in patients in the period before diagnosis of chronic obstructive pulmonary disease…”
Get full text